ICRM
AUXL

Insight Capital Research & Management’s AUXILIUM PHARAMCEUTICALS INC AUXL Stock Holding History

Insight Capital Research & Management’s Portfolio AUXL Stock Details AUXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-197,647
Closed -$5.37M – 166
2014
Q1 		$5.37M Buy
+197,647
New +$5.25M 1.24% 32

Other funds holding AUXL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Insight Capital Research & Management's AUXL Position: Q2 2014 in Review

Insight Capital Research & Management sold out of AUXILIUM PHARAMCEUTICALS INC (AUXL) in Q2 2014, closing a stake of 197,647 shares — an estimated $5.37M sold.

Insight Capital Research & Management first reported a position in AUXL in Q1 2014 and held it in 1 quarter. The position peaked at $5.37M in Q1 2014. 152 funds tracked by Wall St. Rank hold AUXL as of Q2 2014.

  • Insight Capital Research & Management reported no remaining AUXILIUM PHARAMCEUTICALS INC position as of Q2 2014 after selling out during the quarter.
  • Insight Capital Research & Management sold 197,647 AUXILIUM PHARAMCEUTICALS INC shares in Q2 2014, an estimated $5.37M.
  • Insight Capital Research & Management first reported a position in AUXILIUM PHARAMCEUTICALS INC in Q1 2014 and held it in 1 quarter.
  • Insight Capital Research & Management's AUXILIUM PHARAMCEUTICALS INC position peaked at $5.37M in Q1 2014.
  • 152 funds tracked by Wall St. Rank held AUXILIUM PHARAMCEUTICALS INC as of Q2 2014.

Based on Insight Capital Research & Management's 13F filing for Q2 2014, filed 13 Aug 2014.